| 发明名称 |
MULTI-METABOLITES PLATFORM FOR DIAGNOSIS OF ACUTE CORONARY SYNDROME |
| 摘要 |
The present disclosure provides a multi-metabolite platform using one or more metabolite selected from a group consisting of tryptophan, homoserine, fatty acid (16:1), fatty acid (18:0), fatty acid (18:1), fatty acid (18:2), fatty acid (22:6), phosphatidylcholine (PC) (34:2), PC (34:3), lysophosphatidylcholine (lysoPC) (16:0), lysoPC (18:0), lysoPC (20:3), lysoPC (20:4), lysoPC (22:6), monoglyceride (18:1/0:0/0:0) and sphingomyelin (d18:2/16:0) as a biomarker, which can diagnose acute coronary syndrome as well as the symptoms occurring prior to the onset of the disease simply and accurately through in-vivo level analysis. |
| 申请公布号 |
US2016305931(A1) |
申请公布日期 |
2016.10.20 |
| 申请号 |
US201514795163 |
申请日期 |
2015.07.09 |
| 申请人 |
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
发明人 |
JUNG Byung Hwa;CHOI Jong Min;SEO Hong Seog |
| 分类号 |
G01N33/49 |
主分类号 |
G01N33/49 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A kit for diagnosis of acute coronary syndrome, comprising an in-vivo level detector of one or more metabolite selected from a group consisting of tryptophan, homoserine, phosphatidylcholine (PC) (34:2), PC (34:3), lysophosphatidylcholine (lysoPC) (16:0), lysoPC (20:4), lysoPC (22:6), monoglyceride (18:1/0:0/0:0) and sphingomyelin (d18:2/16:0). |
| 地址 |
Seoul KR |
